PAR is still shaping up well for a run. Exhaustive research report out over the weekend with multi bag valuations, and AGM today. http://www.fiftyonecapital.com/market-insights/2018/11/24/paradigm-biopharmaceuticals-ltd
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game